MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LYEL has $350,626K in assets. $76,961K in debts. $90,770K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
723.48%
Quick Ratio
723.48%
Cash Ratio
245.68%
Debt to Asset Ratio
21.95%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
90,770 60,181 123,575 98,804
Marketable securities
163,253 187,039 196,049 177,986
Prepaid expenses and other current assets
13,281 13,719 8,577 5,424
Total current assets
267,304 260,939 328,201 282,214
Restricted cash
1,586 1,585 1,585 1,584
Marketable securities, non-current
6,954 0 0 20,059
Other investments
19,000 19,000 19,000 19,000
Property and equipment, net
32,720 34,771 36,722 39,115
Operating lease right-of-use assets
17,828 18,871 19,912 20,951
Other non-current assets
5,234 4,886 2,545 2,530
Total assets
350,626 340,052 407,965 385,453
Accounts payable
5,468 2,893 2,568 3,379
Contingent consideration payable
-0 0 5,525
Accrued liabilities and other current liabilities
31,479 46,519 29,310 27,999
Total current liabilities
36,947 49,412 31,878 36,903
Operating lease liabilities, non-current
39,487 41,921 44,285 46,597
Other non-current liabilities
527 517 2,681 3,030
Total liabilities
76,961 91,850 78,844 86,530
Common stock, value, issued
2 2 2 1
Additional paid-in capital
1,917,379 1,867,512 1,807,749 1,738,850
Accumulated other comprehensive (loss) income
-9 242 201 57
Accumulated deficit
-1,643,707 -1,619,554 -1,478,831 -1,439,985
Total stockholders equity
273,665 248,202 329,121 298,923
Total liabilities and stockholders equity
350,626 340,052 407,965 385,453
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$163,253K Cash and cashequivalents$90,770K Prepaid expenses andother current assets$13,281K Total current assets$267,304K Property and equipment,net$32,720K Other investments$19,000K Operating leaseright-of-use assets$17,828K Marketable securities,non-current$6,954K Other non-currentassets$5,234K Restricted cash$1,586K Total assets$350,626K Total liabilities andstockholders equity$350,626K Total stockholdersequity$273,665K Total liabilities$76,961K Accumulated deficit-$1,643,707K Accumulated othercomprehensive (loss) income-$9K Additional paid-in capital$1,917,379K Operating leaseliabilities, non-current$39,487K Total currentliabilities$36,947K Other non-currentliabilities$527K Common stock, value,issued$2K Accrued liabilities andother current...$31,479K Accounts payable$5,468K

Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma, Inc. (LYEL)